@WildImmunity
wildimmunity.bsky.social
@WildImmunity
@wildimmunity.bsky.social
A/Prof Andrew Flies. #wild #immunology #vaccines Tasmanian devil wildlife #DFTD #UTAS #Menzies #ARC #FutureFellow looking for #antechinus #dunnart and other #dasyurid. Runner and digger in my spare time. Former farm worker in my youth. Love #Tasmania
Pinned
Exciting night on the #TasmanPeninsula! #TasmanianDevil recorded trying to #hunt a #BrushtailPossum in a tree.
This is likely a young devil trying to climb the tree. #EaglehawkNeck @utas.bsky.social
Reposted by @WildImmunity
🚨 New publication alert! 🚨
Thrilled to share our latest research out today in @jclinical-invest.bsky.social! This work is another great outcome of my amazing clinical research partnership with first author Samantha Chan and RMH. @wehi-research.bsky.social #immunology #research #JCI
JCI - A dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ
www.jci.org
April 15, 2025 at 11:34 PM
Reposted by @WildImmunity
This week, Australia became the first country to ban children aged under 16 from using most social media platforms

go.nature.com/4pXa8Je
Australia’s world-first social media ban is a ‘natural experiment’ for scientists
Researchers will study the effects of the policy on young people’s mental health, social interactions and political engagement.
go.nature.com
December 11, 2025 at 11:02 AM
@jaseziv.bsky.social can you your model be adapted to show attendance over time following new stadium construction? I suspect attendance would spike, but would only remain high if the team has a high winning percentage.
medium.com/data-science...
Building a Linear Regression Model in R to Predict AFL Crowds
Can this model beat the baseline?
medium.com
November 23, 2025 at 9:44 AM
Peanut allergies have dropped dramatically in the US. Is that likely to happen in Australia?
theconversation.com/peanut-aller...
Peanut allergies have dropped dramatically in the US. Is that likely to happen in Australia?
A US study found peanut allergy diagnoses decreased 43% in the years after guidelines changed to recommend introducing these foods early in babies’ diets.
theconversation.com
November 6, 2025 at 2:49 AM
Are you passionate about using your professional skills to support conservation action in Tasmania’s wild places? We are seeking expressions of interest for vacant positions on the Grants Committee.

wildcaretas.org.au/news/TNCF-gr...
Seeking new TNCF Grants Committee members - Wildcare
wildcaretas.org.au
October 31, 2025 at 7:19 PM
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma: Cell www.cell.com/cell/fulltex...
A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma
A personalized neoantigen peptide vaccine formulated with Montanide plus poly-ICLC and administered with local ipilimumab plus systemic nivolumab induces robust neoepitope-specific T cell responses an...
www.cell.com
September 22, 2025 at 11:52 AM
Our amazing team @menzies-research.bsky.social @utas.edu.au is still accepting applications for a PhD scholarship this week. Not many scholarships available, so domestic applicants will have the best chance of winning the scholarship.
www.utas.edu.au/research/deg...
Available projects for research degrees | University of Tasmania - Co-infection and immunity in wildlife
Two independent Tasmanian devil facial tumours (DFT1, DFT2) are infect...
www.utas.edu.au
September 15, 2025 at 12:18 PM
Reposted by @WildImmunity
The Multiple Sclerosis Research Flagship and Centre of Research Excellence (MS-CRE) at Menzies is recruiting PhD students across a range of disciplines. Successful applicants will join one of the largest Multiple Sclerosis research groups in the world. More: msresearchflagship.org.au/multiple-scl...
September 4, 2025 at 3:38 AM
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial - The Lancet www.thelancet.com/journals/lan...
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial
RmAb was safe and well tolerated and showed protective efficacy against rabies. A PEP regimen containing RmAb plus PVRV was immunogenic with long-term persistence of immune response.
www.thelancet.com
September 5, 2025 at 8:53 PM
Loss of ICOSL expression in the progression to cervical carcinoma | PNAS www.pnas.org/doi/10.1073/...
PNAS
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans...
www.pnas.org
September 3, 2025 at 9:53 AM
Early-life infectious disease exposure, the “hygiene hypothesis,” and lifespan: Evidence from hookworm disease | PNAS www.pnas.org/doi/10.1073/...
Early-life infectious disease exposure, the “hygiene hypothesis,” and lifespan: Evidence from hookworm disease | PNAS
Exposure to infectious disease in early life may have long-term ramifications for health and lifespan. However, reducing pathogen exposure may not ...
www.pnas.org
September 3, 2025 at 9:38 AM